Double free in Remote Desktop Gateway Service allows an authorized attacker to elevate privileges locally.
Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Tue, 08 Sep 2026 17:30:00 +0000

Type Values Removed Values Added
Description Double free in Remote Desktop Gateway Service allows an authorized attacker to elevate privileges locally.
Title Remote Desktop Gateway Service Elevation of Privilege Vulnerability
First Time appeared Microsoft
Microsoft windows 10 1607
Microsoft windows 10 1809
Microsoft windows Server 2012
Microsoft windows Server 2012 R2
Microsoft windows Server 2016
Microsoft windows Server 2019
Microsoft windows Server 2022
Microsoft windows Server 2025
Weaknesses CWE-415
CPEs cpe:2.3:o:microsoft:windows_10_1607:*:*:*:*:*:*:x86:*
cpe:2.3:o:microsoft:windows_10_1809:*:*:*:*:*:*:x86:*
cpe:2.3:o:microsoft:windows_server_2012:*:*:*:*:*:*:x64:*
cpe:2.3:o:microsoft:windows_server_2012_R2:*:*:*:*:*:*:x64:*
cpe:2.3:o:microsoft:windows_server_2016:*:*:*:*:*:*:*:*
cpe:2.3:o:microsoft:windows_server_2019:*:*:*:*:*:*:*:*
cpe:2.3:o:microsoft:windows_server_2022:*:*:*:*:*:*:*:*
cpe:2.3:o:microsoft:windows_server_2025:*:*:*:*:*:*:*:*
Vendors & Products Microsoft
Microsoft windows 10 1607
Microsoft windows 10 1809
Microsoft windows Server 2012
Microsoft windows Server 2012 R2
Microsoft windows Server 2016
Microsoft windows Server 2019
Microsoft windows Server 2022
Microsoft windows Server 2025
References
Metrics cvssV3_1

{'score': 7, 'vector': 'CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: microsoft

Published:

Updated: 2026-09-08T18:31:05.825Z

Reserved: 2026-08-03T20:46:07.440Z

Link: CVE-2026-69292

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Received

Published: 2026-09-08T18:18:44.423

Modified: 2026-09-08T18:18:44.423

Link: CVE-2026-69292

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses